TG Therapeutics Inc (TGTX.OQ)

TGTX.OQ on NASDAQ Stock Exchange Capital Market

16.44USD
2 Jul 2015
Change (% chg)

-- (--)
Prev Close
$16.44
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
157,092
52-wk High
$20.00
52-wk Low
$7.20

TGTX.OQ

Chart for TGTX.OQ

About

TG Therapeutics, Inc. (TG) is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for b-cell malignancies and autoimmune diseases. As of December 31, 2014, TG had two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a glycoengineered monoclonal antibody... (more)

Overall

Beta: 1.62
Market Cap(Mil.): $832.43
Shares Outstanding(Mil.): 50.63
Dividend: --
Yield (%): --

Financials

  TGTX.OQ Industry Sector
P/E (TTM): -- 454.60 39.81
EPS (TTM): -1.71 -- --
ROI: -76.65 -4.37 16.23
ROE: -78.19 -5.27 17.36
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$25.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks